Lowry Curley

Dr. Lowry Curley is a scientist-entrepreneur who has spent the last 15 years pushing the frontiers of human neurobiology by building next-gen platforms that combine 3D neural tissue engineering, embedded bioelectronics, and AI-driven analytics to transform how we model, understand, and repair the brain. As the founder and CEO of AxoSim, he led the development and launch of industry-leading biomimetic organ-on-a-chip platforms which are now used by over 20 of the world’s top 25 pharmaceutical companies.

Under his leadership, AxoSim grew from a university spinout to a recognized innovation engine in neurobiology, neurotechnology, and biocomputing. He spearheaded product strategy across multiple technology domains, directed IP licensing from Johns Hopkins, University of California San Diego, Tulane University and other top institutions, and led M&A activity to expand AxoSim’s footprint and portfolio. Lowry’s work has helped accelerate human-relevant organoid platform adoption through engagements with regulatory-facing consortia like NIPSI and the 3Rs Collaborative.

Lowry is particularly passionate about applying cutting-edge technology to solve system-level challenges in human health—from disease modeling to functional repair. His experience spans technology commercialization, partnership development, and company building. With expertise across scientific, commercial, operational, and strategic domains, he thrives at the convergence of translational science and high-risk, high-reward innovation.

Lowry earned his PhD in biomedical engineering from Tulane University and a BS in materials engineering from Clemson. As an advisor, consultant, and mentor, Lowry brings a hands-on, mission-driven approach to guiding visionary health technologies across domains from concept to impact.

‍